NDC codes

FDA NDC Directory
Product NDC (as listed)70518-3237Labeler and product segments. Claims need a package NDC.
Product NDC at billing width70518-3237Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
70518-3237-27051832370230 TABLET, FILM COATED in 1 BLISTER PACK (70518-3237-2)Marketed from Feb 11, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Oxcarbazepine
Generic name (nonproprietary)
oxcarbazepine
Active ingredients
Oxcarbazepine — 300 mg/1
Dosage form
Tablet, Film coated
Route
Oral
Labeler
REMEDYREPACK INC.NDC labeler code 70518
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 077802
Marketing start
Listing expires
Other FDA classes
Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers
Product ID 70518-3237_584f6c49-bfb9-3b49-e063-6394a90aeeb3SPL ID 584f6c49-bfb9-3b49-e063-6394a90aeeb3SPL set ID a2032bcc-2da5-45e5-aa3f-ddbf50909df8RxCUI 312137UNII VZI5B1W380
Pharmacologic class
Anti-epileptic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518323702 followed by a unit qualifier and the quantity

Package 70518-3237-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

Oxcarbazepine tablets are indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures. Oxcarbazepine tablets are indicated for: Adults: Monotherapy or adjunctive therapy in the treatment of partial-onset seizures Pediatrics: Monotherapy in the treatment of partial-onset seizures in children 4 to 16 years Adjunctive therapy in the treatment of partial-onset seizures in children 2 to 16 years ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70518-3237

What is NDC 70518-3237?
70518-3237 is the product NDC for Oxcarbazepine, Oxcarbazepine 300 mg/1 tablet, film coated, listed with the FDA by REMEDYREPACK INC.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Oxcarbazepine.
What is the active ingredient?
Oxcarbazepine.
Who is the labeler?
REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Oxcarbazepine?
118 other product NDCs are listed under this name. See all Oxcarbazepine NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Oxcarbazepine NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
OxcarbazepineOxcarbazepine 600 mg/1Tablet, Film coatedOralZameer Pharmaceuticals LLC90096-17390096-0173-01
OxcarbazepineOxcarbazepine 150 mg/1Tablet, Film coatedOralZameer Pharmaceuticals LLC90096-17190096-0171-01
OxcarbazepineOxcarbazepine 300 mg/1Tablet, Film coatedOralZameer Pharmaceuticals LLC90096-17290096-0172-01
OxcarbazepineOxcarbazepine 300 mg/5mLSuspensionOralNovadoz Pharmaceuticals LLC72205-35472205-0354-85
OxcarbazepineOxcarbazepine 600 mg/1Tablet, Film coatedOralREMEDYREPACK INC.70518-466470518-4664-0070518-4664-01
OxcarbazepineOxcarbazepine 300 mg/1Tablet, Film coatedOralREMEDYREPACK INC.70518-466370518-4663-0070518-4663-01
OxcarbazepineOxcarbazepine 300 mg/1Tablet, Film coatedOralCoupler LLC67046-208467046-2084-03
OxcarbazepineOxcarbazepine 300 mg/1Tablet, Film coatedOralCoupler LLC67046-086867046-0868-03
OxcarbazepineOxcarbazepine 600 mg/1Tablet, Film coatedOralCoupler LLC67046-017967046-0179-03
OxcarbazepineOxcarbazepine 150 mg/1Tablet, Film coatedOralMajor Pharmaceuticals0904-759300904-7593-61

All 119 Oxcarbazepine NDCs

Other NDCs under ANDA 077802

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077802
ProductStrengthForm · routeLabelerProduct NDC
OxcarbazepineOxcarbazepine 600 mg/1Tablet, Film coatedOralCoupler LLC67046-0179
OxcarbazepineOxcarbazepine 600 mg/1Tablet, Film coatedOralREMEDYREPACK INC.70518-3197
OxcarbazepineOxcarbazepine 600 mg/1Tablet, Film coatedOralGlenmark Pharmaceuticals Inc., USA68462-139
OxcarbazepineOxcarbazepine 150 mg/1Tablet, Film coatedOralGlenmark Pharmaceuticals Inc., USA68462-137
OxcarbazepineOxcarbazepine 300 mg/1Tablet, Film coatedOralGlenmark Pharmaceuticals Inc., USA68462-138
OxcarbazepineOxcarbazepine 150 mg/1Tablet, Film coatedOralProficient Rx LP71205-411
OxcarbazepineOxcarbazepine 300 mg/1Tablet, Film coatedOralCoupler LLC67046-0868
OxcarbazepineOxcarbazepine 150 mg/1Tablet, Film coatedOralDirect_rx72189-573

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in